Cargando…
Angiogenesis Inhibitors for Head and Neck Squamous Cell Carcinoma Treatment: Is There Still Hope?
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) carries poor survival outcomes despite recent progress in cancer treatment in general. Angiogenesis is crucial for tumour survival and progression. Therefore, several agents targeting the pathways that mediate angiogenesis have been developed...
Autores principales: | Hyytiäinen, Aini, Wahbi, Wafa, Väyrynen, Otto, Saarilahti, Kauko, Karihtala, Peeter, Salo, Tuula, Al-Samadi, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236814/ https://www.ncbi.nlm.nih.gov/pubmed/34195084 http://dx.doi.org/10.3389/fonc.2021.683570 |
Ejemplares similares
-
Evaluation of in vitro and in vivo personalized cancer treatment assays for oral squamous cell carcinoma
por: Wahbi, Wafa, et al.
Publicado: (2023) -
High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma
por: Tuomainen, Katja, et al.
Publicado: (2021) -
PCR-based zebrafish model for personalised medicine in head and neck cancer
por: Al-Samadi, Ahmed, et al.
Publicado: (2019) -
FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma
por: Keski-Säntti, Harri, et al.
Publicado: (2014) -
The effect of matrices on the gene expression profile of patient-derived head and neck carcinoma cells for in vitro therapy testing
por: Hyytiäinen, Aini, et al.
Publicado: (2023)